Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-24

Clinical Trial Update: Naringenin Supplementation in Bone Fracture Patients [NA]

View source ↗

Summary

The document indicates a clinical trial evaluating naringenin supplementation in patients with bone fractures, currently in the recruitment phase.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naringenin (naringenin)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Bone Fractures | NA | Status: RECRUITING